Stock market
Pharma: Finanzinvestor EQT will Dax-Konzern Qiagen übernehmen
Der Pharmadienstleister Qiagen wird von einem schwedischen Finanzinvestor umworben. Der legt ein milliardenschweres Angebot für den Diagnostikkonzern vor.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More on Stock market
- Meta's Zuckerberg pitches AI successes to investors with 26% rise in quarterly revenueMeta Platforms CEO Mark Zuckerberg touted the company's progress on artificial intelligence during an earnings call on Wednesday and called for more investment. The tech giant's Muse AI agent has g...
- Asian stocks tumble, bitcoin retreats as China enters bear marketTechnology shares led regional losses as mixed U.S. earnings unsettled investors and Brent crude climbed above $112 a barrel.
- Global stocks tumble as oil prices riseChina’s CSI 300 index sheds 1.8% and Eurozone bond sell-off deepens
- India Ramps Up Coal Supplies to Record High as Power Crisis LoomsCoal supply for power plants in India is ramping up and will soon normalize, an unnamed senior official from the energy ministry in New Delhi said, as quoted by Reuters. At the moment, coal power g...
- Dow Jones futures slip as tech-driven rally loses momentumDow Jones futures decline by 0.58% to trade near 52,750 during European hours on Thursday. S&P 500 futures fall 0.97% to trade around 7,720, while Nasdaq 100 futures plunge 1.69% to trade near 29,500.
- Earnings call transcript: Inchcape Q3 2026 shares fall as australia drags margins